Organon & Co.
- OGN
- NYSE
- Drug manufacturers
- Women's Health Pharma
- Contraceptives & Fertility
$13.76
Quote Oct 16, 2026, 08:00 PM UTC
+0.51%over the last month
Max drawdown −0.5%From 1-month high −0.4%3 months +2.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$3.61B
Quote Oct 16
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$14.00
+1.7% from here
Floor
$13.75
0.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about OGNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Drug manufacturers
Employees
10,000